NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase STEL Q1 2026 Earnings Strong EPS Beat Amid Marginal Stock Decline Monarch Casino Resort Inc MCRI Q1 2026 Earnings EPS Surges 349 Above Expectations GeneDx Holdings Corp WGS Q1 2026 Earnings Deep EPS Miss Overshadows Progress PG Q1 2026 Earnings Slight EPS Miss Weighs on Shares Dianthus Therapeutics Q1 2026 Earnings EPS Beat Driven by Cost Discipline Yet Shares Slip